Page 808 - Cote clinical veterinary advisor dogs and cats 4th
P. 808

Gastrinoma  382.e3


                  +
                +/
             ○   H K -ATPase (proton pump) inhibitors   Recommended Monitoring    SUGGESTED READING
               (omeprazole 0.7-1.5 mg/kg PO q 12-24h);   According to clinical signs  Gal A, et al: An unusual clinical presentation of a
  VetBooks.ir  ○   Somatostatin analog (octreotide 10-    PROGNOSIS & OUTCOME     ADDITIONAL SUGGESTED                Diseases and   Disorders
               considered superior to H2-receptor antago-
                                                                                   dog with gastrinoma. Can Vet J 52:641, 2011.
               nists for suppression of acid secretion
               40 mcg/DOG q 8-12h)
                                               •  Animals  that  are  managed  medically  and
           •  Promote healing.                 •  Poor due to high rate of metastasis  READINGS
             ○   Sucralfate 0.25-1 g/DOG PO q 6-12h  surgically live 1 week to 18 months (mean,   Hughes SM: Canine gastrinoma: a case study and
                                                                                   literature review of therapeutic options. N Z Vet
             ○   Misoprostol 1-7.5 mcg/kg PO q 8h  4.8 months).                    J 54:242, 2006.
           •  Surgical and medical management for GI                              Parente NL, et al: Serum concentrations of gastrin
             ulceration/perforation             PEARLS & CONSIDERATIONS            after famotidine and omeprazole administration to
                                                                                   dogs. J Vet Intern Med 28:1465, 2014.
           Chronic Treatment                   Comments                           Simpson K, et al: Diagnosis and treatment of
           •  Acute  treatment  management,  along  with   A palpable abdominal mass or one that is visual-  gastrinoma. Semin Vet Med Surg (Small Anim)
             antiemetics                       ized on ultrasound or at surgery is uncommon   12:274, 1997.
           •  Surgical  debulking  of  the  primary  and   with gastrinoma.
             metastatic  lesions  decreases  clinical  signs                      RELATED CLIENT EDUCATION
             associated with gastrinomas.      Technician Tips                    SHEETS
           •  Chemotherapy,  receptor-mediated  radio-  Ensure that antacid medication has been
             therapy, and long-acting somatostatin   discontinued for 7 days before obtaining a   Consent to Perform Abdominal Ultrasound
             analogs (+/− alpha-interferon) yield mixed    fasting serum gastrin level.  Consent to Perform Endoscopy, Upper GI
             responses.                                                             (Gastroduodenoscopy)
                                               Client Education
           Possible Complications              •  Monitor for recurrence of clinical signs.  AUTHOR: M. Raquel Brown, DVM, DACVIM
           Anemia;  GI  ulceration/perforation  if  hyper-  •  Rapid deterioration is possible if GI perfora-  EDITOR: Rance K. Sellon, DVM, PhD, DACVIM
           acidity is not controlled; common bile duct   tion occurs.
           obstruction if due to a duodenal gastrinoma




















































                                                      www.ExpertConsult.com
   803   804   805   806   807   808   809   810   811   812   813